...
首页> 外文期刊>Metallomics. integrated biometal science >Defining the metal binding pathways of human metallothionein 1a: balancing zinc availability and cadmium seclusion
【24h】

Defining the metal binding pathways of human metallothionein 1a: balancing zinc availability and cadmium seclusion

机译:定义人类金属硫蛋白1a的金属结合途径:平衡锌的有效性和镉的逸出

获取原文
获取原文并翻译 | 示例
           

摘要

Metallothioneins (MTs) are cysteine-rich, metal-binding proteins that are found throughout Nature. This ubiquity highlights their importance in essential metal regulation, heavy metal detoxification and cellular redox chemistry. Missing from the current description of MT function is the underlying mechanism by which MTs achieve their proposed biological functions. To date, there have been conflicting reports on the mechanism of metal binding and the structures of the metal binding intermediates formed during metalation of apoMTs. The form of the metal-bound intermediates dictates the metal sequestering and metal-donating properties of the protein. Through a detailed analysis of spectral data from electrospray ionization mass spectromeric and circular dichroism methods we report that Zn(II) and Cd(II) metalation of the human MT1a takes place through two distinct pathways. The first pathway involves formation of beaded structures with up to five metals bound terminally to the 20 cysteines of the protein via a noncooperative mechanism. The second pathway is dominated by the formation of the four-metal domain cluster structure M4SCYS11 via a cooperative mechanism. We report that there are different pathway preferences for Zn(II) and Cd(II) metalation of apo-hMT1a. Cd(II) binding follows the beaded pathway above pH 7.1 but beginning below pH 7.1 the clustered (Cd4Scys11) pathway begins to dominate. In contrast, Zn(II) binding follows the terminal, "beaded'', pathway at all physiologically relevant pH (pH > 5.2) only following the clustered pathway below pH 5.1. The results presented here allow us to reconcile the conflicting reports concerning the presence of different metalation intermediates of MTs. The conflict regarding cooperative versus noncooperative binding mechanisms is also reconciled with the experimental results described here. These two metal-specific pathways and the presence of radically different intermediate structures provide insight into the multi-functional nature of MT: binding Zn(II) terminally for donation to metalloenzymes and sequestering toxic Cd(II) in a cluster structure.
机译:金属硫蛋白(MTs)是富含半胱氨酸的金属结合蛋白,遍布整个自然界。这种普遍性突显了它们在基本金属调节,重金属排毒和细胞氧化还原化学中的重要性。当前对MT功能的描述中缺少的是MT实现其提议的生物学功能的基本机制。迄今为止,关于金属结合的机理和在apoMT金属化过程中形成的金属结合中间体的结构的报道相互矛盾。金属结合的中间体的形式决定了蛋白质的金属螯合和金属供体特性。通过对电喷雾电离质谱和圆二色性方法的光谱数据进行详细分析,我们报告了人MT1a的Zn(II)和Cd(II)金属化是通过两种不同的途径发生的。第一条途径涉及通过非合作机制,在多达20个半胱氨酸末端结合多达5个金属的珠状结构。第二种途径是通过协同机制形成的四金属畴簇结构M4SCYS11。我们报告说有不同的途径偏好的apo-hMT1a的Zn(II)和Cd(II)金属化。 Cd(II)的结合遵循pH 7.1以上的串珠途径,但从pH 7.1以下开始,聚集的(Cd4Scys11)途径开始占主导地位。相反,在所有生理相关的pH值(pH> 5.2)下,Zn(II)的结合都遵循最终的“串珠”途径,只有在pH值低于5.1的情况下才遵循聚集的途径。 MTs的不同金属化中间体的存在。关于合作与非合作结合机制的冲突也与此处描述的实验结果相吻合。这两种金属特异性途径和根本不同的中间体结构的存在提供了对MT多功能性质的洞察力:最终结合Zn(II)以供捐赠给金属酶,并在簇结构中隔离有毒的Cd(II)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号